510(k) Report

510(k) · Cleared

Cleared

Tria Firm Ureteral Stent

K163399510(k) TraditionalCleared Jun 22, 2017199-day reviewClass II21 CFR 876.4620

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Boston Scientific Corporation · FAD Stent, Ureteral

Cleared on Jun 22, 2017 as substantially equivalent to K974541 (Boston Scientific Corp, 1998) after a 199-day review. Its family tree reaches back 1 generation to 1998. 3 later devices descend from it.

Decided
Jun 22, 2017
Review
199 days
Class
Class II
Product code
FAD
Recalls
None
Predicates
1

Its longest line of descent runs back 1 generation to K974541 (1998). 3 later devices descend from it, 1 citing it directly.

Descendants, by generation 1 generation forward: 1 descendant2 generations forward: 2 descendants K974541 · Modified Ureteral Indwelling Catheter/Stent · Boston Scientific Corp · 1998 · recalled0
  1. Root · 1 generation backK974541 Modified Ureteral Indwelling Catheter/StentBoston Scientific Corp · 1998 · Recalled
  2. This deviceK163399 Tria Firm Ureteral StentBoston Scientific Corporation · 2017
  3. Descendant · cites it directly · 2 of its ownK190603 Tria Firm Ureteral StentBoston Scientific Corporation · 2019
  4. Descendant · 2 generations on · 0 of its ownK250824 Percuflex Ureteral Stent; Percuflex Plus Ureteral Stent; Percuflex…Boston Scientific Corporation · 2025
  5. Descendant · 2 generations on · 0 of its ownK191609 Tria Soft Ureteral StentBoston Scientific Corporation · 2019

Most influential descendants

Showing 3 of 3 · See all
  • K190603Tria Firm Ureteral StentBoston Scientific Corporation · 2019 · cites it directly2descendants
  • K250824Percuflex Ureteral Stent; Percuflex Plus Ureteral Stent; Percuflex Plus SureDrive…Boston Scientific Corporation · 2025 · 2 generations on0descendants
  • K191609Tria Soft Ureteral StentBoston Scientific Corporation · 2019 · 2 generations on0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1K974541Modified Ureteral Indwelling Catheter/StentBoston Scientific Corp19982
0 (this device)K163399Tria Firm Ureteral StentBoston Scientific Corporation2017—
+1K190603Tria Firm Ureteral StentBoston Scientific Corporation2019—
+2K250824Percuflex Ureteral Stent; Percuflex Plus Ureteral Stent; Percuflex Plus…Boston Scientific Corporation2025—
+2K191609Tria Soft Ureteral StentBoston Scientific Corporation2019—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
201920
202510
FIG. 1 — Lineage of K163399, 1998–2025Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in FAD? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new FAD device

  1. #1 K251890 Disposable Ureteral Stentsscore 12.4 · 6 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K974541Modified Ureteral Indwelling Catheter/Stent
Summary page 4
…ent, ureteral Classification Name: FAD – Stent, Ureteral Premarket Notification: Contour™ (Modified Ureteral Indwelling Catheter/Stent) Ureteral Stent, K974541, Sep 02, 1998. The Contour Ureteral Stent has not been the subject of a design-related recall. Reference 1 Trade na…
Boston Scientific Corp19982
†K834468Drainage StentMicrovasive19842
†K133700Advanix Pancreatic Stent and Naviflex Rapid Exchange Pancreatic Delivery System and…Boston Scientific Corporation201413
†K022447Bard ER Ureteral Stent with SutureC.R. Bard, Inc.2003—

What descends from it? (3)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K190603Tria Firm Ureteral StentBoston Scientific Corporation20192

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Its one ancestor has a recall.
  • Of its descendants, K190603 (Boston Scientific Corporation, 2019) has gone furthest, with 2 descendants of its own.

How does its category compare?

All FAD devices

FAD Stent, Ureteral: FDA decisions, review times, recalls and adverse event reports over 20 years. 2017, this device’s year, is highlighted.

FDA decisions per year · FAD

4in 2025

2007: 12008: 12010: 12014: 12016: 42017: 82018: 92019: 52020: 12021: 22022: 52024: 12025: 42026 (partial year): 1
2007high 9 (2018) · low 0 (2009)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · FAD

186in 2025

2016: 143 days median2017: 266 days median2018: 258 days median2019: 263 days median2022: 143 days median2025: 186 days median
2007high 266 (2017) · low 143 (2016)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · FAD

4in 2025

2007: 12008: 222009: 22010: 12016: 42019: 62020: 22021: 12022: 92025: 4
2007high 22 (2008) · low 0 (2011)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · FAD

634in 2025

2007: 432008: 762009: 1232010: 782011: 952012: 1312013: 822014: 782015: 1302016: 1822017: 2652018: 2772019: 2612020: 3522021: 5312022: 5592023: 6912024: 6032025: 634
2007high 691 (2023) · low 43 (2007)2025

MAUDE reports naming product code FAD, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071—143
20081—2276
20090—2123
20101—178
20110—095
20120—0131
20130—082
20141—078
20150—0130
201641434182
201782660265
201892580277
201952636261
20201—2352
20212—1531
202251439559
20230—0691
20241—0603
202541864634
20261—0—

What is it indicated for?

The Ureteral Stent is intended to facilitate drainage from the kidney to the bladder via placement endoscopically,

fluoroscopically or during an open surgical procedure by a trained physician.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K163399: Tria Firm Ureteral Stent.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K163399

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026